TY  - JOUR
AU  - González Bayón, Luis Andrés
AU  - Steiner, M.A.
AU  - Vásquez Jiménez, W.
AU  - Asencio Pascual, José Manuel
AU  - Álvarez de la Sierra, P.
AU  - Atahualpa Arenas, F.
AU  - Rodríguez del Campo, J.
AU  - García Sabrido, José Luis
PY  - 2013
DO  - 10.1016/j.ejso.2013.06.022
SN  - 0748-7983
UR  - https://hdl.handle.net/20.500.14352/124989
T2  - European Journal of Surgical Oncology
AB  - AimCytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) has been proposed as treatment for advanced epithelial ovarian carcinoma (EOC). No consensus exists on when to administer CRS + HIPEC during the natural...
LA  - eng
M2  - 1109
PB  - Elsevier
KW  - Advanced epithelial ovarian carcinoma
KW  - Cytoreductive surgery
KW  - Hyperthermic intraperitoneal chemotherapy
KW  - Upfront therapy
KW  - First recurrence therapy
KW  - Second or subsequent recurrence therapy
TI  - Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: upfront therapy, at first recurrence, or later?
TY  - journal article
VL  - 39
ER  -